Company: DHR
Filing Date: 2025-02-20
Form Type: 10-K
Source: 0000313616-25-000043
Chunk: 13

Company: DANAHER CORP /DE/
Filing Date: 2025-02-20
Form: 10-K
Item: Item 8
Chunk 13
---
990 $4,553 Investments—Investments over which the Company has a significant influence but not a controlling interest, are accounted for using the equity method of accounting which requires the Company to record its initial investment at cost and adjust the balance each period for the Company’s share of the investee’s income or loss and dividends paid.  The Company also invests in start-up companies where the Company has neither control of nor significant influence over the investee.  The Company measures these non-marketable equity securities at fair value and recognizes changes in fair value in net earnings.  For securities without readily available fair values, the Company has elected the measurement alternative to record these investments at cost and to adjust for impairments and observable price changes with a same or 

62

similar security from the same issuer within net earnings (the “Fair Value Alternative”).  Additionally, the Company is a limited partner in partnerships that invest in start-up companies.  While the partnerships record these investments at fair value, the Company’s investment in the partnerships is accounted for under the equity method of accounting.  The Company made minority investments in equity method investments and non-marketable equity securities totaling $331 million, $172 million and $523 million in 2024, 2023 and 2022, respectively, including investments in partnerships of $174 million, $71 million and $283 million in 2024, 2023 and 2022, respectively.  The Company recorded net realized and unrealized gains and losses related to changes in the fair value of these investments, as well as impairments to equity-method investments in other income (expense), net, in the accompanying Consolidated Statements of Earnings.  Refer to Notes 8 and 11 for additional information about the Company’s investments. Other Assets—Other assets principally include operating lease right-of-use (“ROU”) assets, noncurrent deferred tax assets and other investments.Fair Value of Financial Instruments—The Company’s financial instruments consist primarily of cash and cash equivalents, trade accounts receivable, investments in equity securities, available-for-sale debt securities and cross-currency swaps, obligations under trade accounts payable and short and long-term debt.  Due to their short-term nature, the carrying values for cash and cash equivalents, trade accounts receivable and trade accounts payable approximate fair value.  Refer to Note 11 for the fair values of the Company’s investments in equity securities, available-for-sale debt securities and cross-currency swaps and other obligations.Goodwill and Other Intangible Assets—Goodwill and